BRIEF-Alpine Immune Sciences And Horizon Therapeutics PLC Announce Exclusive License And Collaboration DEAL

BY Reuters
— 9:41 AM ET 12/16/2021

Dec 16 (Reuters) - Horizon Therapeutics PLC (HZNP):

* ALPINE IMMUNE SCIENCES AND HORIZON THERAPEUTICS PLC ANNOUNCE EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT TO DEVELOP NOVEL PROTEIN-BASED THERAPIES FOR AUTOIMMUNE AND INFLAMMATORY DISEASES Source text for Eikon: Further company coverage:

Copyright © Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Stock Details

Enter Company or Symbol. Press down arrow for suggestions, or Escape to return to entry field.

RELATED RESOURCES

BRIEF-Alpine Immune Sciences And Horizon Therapeutics PLC Announce Exclusive License And Collaboration DEAL

More HZNP News